Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring

Longo, Miriam; Scappaticcio, Lorenzo; Petrizzo, Michela; Castaldo, Filomena; Sarnataro, Annalisa; Forestiere, D; Caiazzo, F; Bellastella, Giuseppe; Maiorino, Maria Ida; Capuano, Annalisa; Esposito, Katherine

doi:10.1007/s40618-021-01669-3

Cited by 9 publications

(9 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Blood glucose levels were restored in a fairly short time to previous levels, coinciding with the end of the viral infection. A similar observation was reported among 32 adults with T1D during the infection period ( 33 ). Thus, COVID-19 infection among young people with T1D probably resembles the effects of other viral infections during sick days ( 34 ).…”

Section: Discussionsupporting

confidence: 88%

Symptoms and Glycemic Control in Young People With Type 1 Diabetes Following SARS-CoV-2 Infection: An Observational Study

Nimri

Rachmiel

Yackobovitch‐Gavan

et al. 2022

The Journal of Clinical Endocrinology &Amp; Metabolism

View full text Add to dashboard Cite

Objective To describe clinical manifestations of SARS-CoV-2 infection in children, adolescents, and young adults with established type 1 diabetes and explore the effects of COVID-19 on glycemic control and disease course. Methods Observational study conducted at three pediatric diabetes clinics in Israel between mid-March-2020 and mid-March-2021. Included were young people with established type 1 diabetes, <30years, who tested positive for SARS-CoV-2 (qRT-PCR). Data was collected from medical files, diabetes devices, and COVID-19 questionnaire. Outcome measures were analyzed by presence/absence of clinical symptoms (symptomatic/asymptomatic) and by age group (pediatric, <19years/young adults, 19-30years). Results Of 132 patients, mean age 16.9±5.3years, with COVID-19 confirmed infection, 103 (78%) had related symptoms; the most common were headaches, fatigue, fever and loss of sense of smell. All had mild disease course, but four required hospitalization and two cases were directly related to COVID-19 infection (pleuropneumonia in a patient with immunodeficiency syndrome, one case of diabetic-ketoacidosis). Logistic regression analysis showed that age (OR=1.11, 95%CI, 1.01, 1.23; P=0.033), elevated glucose levels (OR=5.23, 95%CI, 1.12, 24.41; P=0.035) and comorbidities (OR=8.21, 95%CI, 1.00, 67.51; P=0.050) were positively associated with symptomatic infection. Persistent symptoms occurred in 16.5% of the cohort over a median of 6.7 months; age (OR=1.14, 95%CI, 1.01, 1.29; P=0.030) and elevated glucose levels (OR=3.42, 95%CI, 1.12, 10.40; P=0.031) were positively associated with persistent symptoms. Usually, no change was reported in glucose levels (64%) except for a temporary deterioration in glycemic control during the short infection period. Conclusions Young people with established type 1 diabetes experience mild COVID-19 infection. Elevated glucose levels during COVID-19 infection and older age were associated with prolonged disease course.

show abstract

Section: Discussionsupporting

confidence: 88%

Symptoms and Glycemic Control in Young People With Type 1 Diabetes Following SARS-CoV-2 Infection: An Observational Study

Nimri

Rachmiel

Yackobovitch‐Gavan

et al. 2022

The Journal of Clinical Endocrinology &Amp; Metabolism

View full text Add to dashboard Cite

show abstract

“…Furthermore, the restriction of the survey to a cohort of T1D patients followed by a single center and mainly from the Liguria region limits the generizability of the results. Our study shows high patient and parental satisfaction, probably also related to the efficacy of the new technological devices and to the correct management of diabetes, which was not limited by the follow-up via televisits ( 29 , 30 ). The strength of our study is that, to our knowledge, it is the first survey focused on patient satisfaction of telemedicine in a pediatric and young population with type 1 diabetes.…”

Section: Discussionmentioning

confidence: 60%

Patient Satisfaction of Telemedicine in Pediatric and Young Adult Type 1 Diabetes Patients During Covid-19 Pandemic

Bassi

Strati

Parodi

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

The aim of this study was to evaluate the satisfaction of the use of telemedicine and telenursing in children and young adults with Type 1 Diabetes and their families followed in the Regional Pediatric Diabetes Center of Giannina Gaslini Institute (Liguria, Italy). An anonymous survey form was administered to 290 patients (138 filled out by caregivers and 152 by patients). The questionnaire consisted of two parts: the first one included a series of questions related to the patient's personal and medical data; the second one was directed toward the satisfaction in the use of telemedicine and telenursing during Covid-19 pandemic. The data collected showed that 92.4% of the population was overall very satisfied with the quality of the service provided. Satisfaction was much higher especially in those who live outside of the province of Genoa (p = 0.017) and in those on insulin pump treatment (p = 0.037). Telemedicine and telenursing have an essential role in diabetology and are highly appreciated in our Center, where most patients prefer to continue regular follow-up via video-call as well as in person. Telenursing was also proved to be an effective and appreciated tool for educating and supporting patients using insulin pumps and glucose sensors.

show abstract

“…We would like to share ideas on "Glucose control in homeisolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring [1]." Longo et al concluded that "Young home-isolated patients with type 1 diabetes and COVID-19 showed a worsening of …infection [1]." In general, COVID-19 can affect glucose metabolism and it might result in elevation of blood glucose and hemoglobin A1C [2].…”

Section: Dear Editormentioning

confidence: 99%

Glucose control in type 1 diabetes and COVID-19

Mungmunpuntipantip¹,

Wiwanitkit

2021

J Endocrinol Invest

View full text Add to dashboard Cite

Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring

Cited by 9 publications

References 25 publications

Symptoms and Glycemic Control in Young People With Type 1 Diabetes Following SARS-CoV-2 Infection: An Observational Study

Symptoms and Glycemic Control in Young People With Type 1 Diabetes Following SARS-CoV-2 Infection: An Observational Study

Patient Satisfaction of Telemedicine in Pediatric and Young Adult Type 1 Diabetes Patients During Covid-19 Pandemic

Glucose control in type 1 diabetes and COVID-19

Contact Info

Product

Resources

About